Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

CDRT15 Inhibitors

CDRT15 inhibitors are a class of chemical compounds specifically designed to inhibit the activity of CDRT15, a protein that plays a role in cellular regulatory processes, potentially involving gene expression, signal transduction, or protein-protein interactions. The exact biological function of CDRT15 is still being explored, but it is believed to be involved in critical molecular pathways that influence cellular growth, differentiation, and stress responses. CDRT15 inhibitors function by binding to specific sites on the protein, disrupting its normal activity or its interaction with other cellular components. These inhibitors provide a valuable tool for studying the molecular mechanisms governed by CDRT15, allowing researchers to better understand its role in the broader context of cellular function and regulation.

Structurally, CDRT15 inhibitors are designed to target key functional domains within the protein, such as regions involved in binding to cofactors, substrates, or other proteins. These inhibitors may act by mimicking natural ligands or binding partners, thereby competing with the native molecules and preventing CDRT15 from performing its normal functions. Alternatively, they may induce conformational changes in the protein by binding to allosteric sites, reducing its activity. The interaction between CDRT15 inhibitors and the protein typically involves non-covalent interactions like hydrogen bonding, ionic interactions, or hydrophobic forces, which stabilize the inhibitor within the binding site. Techniques such as molecular docking, X-ray crystallography, and structure-based design are often employed to optimize the potency and selectivity of CDRT15 inhibitors. Through the use of these inhibitors, researchers can explore the precise role of CDRT15 in cellular pathways, shedding light on how it contributes to key processes such as growth, signaling, and cellular homeostasis.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that can broadly target protein kinases involved in the signaling pathways, possibly affecting the phosphorylation state of CDRT15 or its interacting partners.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A specific inhibitor of PI3K, which could influence downstream signaling pathways involving CDRT15 by altering the phosphorylation and activation state of proteins within the pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can suppress the downstream effects of pathways involving CDRT15, potentially affecting the protein's role in cell growth and proliferation.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

A selective inhibitor of MEK, which could disrupt the MAPK/ERK pathway and thereby influence the activity of CDRT15 if it is part of this signaling cascade.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAPK inhibitor that can modulate inflammatory responses and stress-activated pathways that CDRT15 may be involved in.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Another MEK inhibitor that can prevent the activation of the MAPK/ERK pathway, potentially affecting the functional role of CDRT15 within this signaling network.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which can alter the signaling pathways that involve CDRT15, particularly those associated with apoptosis and cell survival.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that can lead to the accumulation of polyubiquitinated proteins, potentially including CDRT15, thereby affecting its degradation and turnover.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

A SERCA pump inhibitor that leads to increased cytosolic calcium levels, which could influence numerous signaling pathways, including those involving CDRT15.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

An immunosuppressant that inhibits calcineurin, thereby potentially affecting the dephosphorylation of proteins within CDRT15-related signaling pathways.